Results 221 to 230 of about 356,273 (249)
Some of the next articles are maybe not open access.
Critical Reviews in Oncology/Hematology, 2006
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
COLOMBO, NICOLETTA +6 more
openaire +2 more sources
Ovarian cancer accounts for 4% of all cancers in women and is the leading cause of death from gynaecologic malignancies. Because early-stage ovarian cancer is generally asymptomatic, approximately 75% of women present with advanced disease at diagnosis. Survival is highly dependent on stage of disease: 5-year survival in patients with early-stage is 80-
COLOMBO, NICOLETTA +6 more
openaire +2 more sources
Seminars in Oncology, 2001
Newer agents and combinations are needed in order to improve current results in the treatment of ovarian cancer. Gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) is a novel agent with a unique mechanism of action that has shown consistent activity as a single-agent in platinum-resistant ovarian cancer, with remission rates of nearly 20 ...
M, Orlando, M, Mandachain
openaire +2 more sources
Newer agents and combinations are needed in order to improve current results in the treatment of ovarian cancer. Gemcitabine (Gemzar; Eli Lilly and Company, Indianapolis, IN) is a novel agent with a unique mechanism of action that has shown consistent activity as a single-agent in platinum-resistant ovarian cancer, with remission rates of nearly 20 ...
M, Orlando, M, Mandachain
openaire +2 more sources
Journal of Reproductive Immunology, 1998
Previous observations from our laboratory have demonstrated that the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumors and in the majority of postmenopausal women with mucinous ovarian cancers.
H G, Burger +13 more
openaire +3 more sources
Previous observations from our laboratory have demonstrated that the levels of immunoreactive inhibin (ir-inh) are elevated in almost all patients with granulosa cell tumors and in the majority of postmenopausal women with mucinous ovarian cancers.
H G, Burger +13 more
openaire +3 more sources
Seminars in Oncology Nursing, 2002
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire +2 more sources
To review the progress in the management of ovarian cancer in the last decade and future directions.Research studies, review articles, and abstracts.There is an increased understanding of ovarian cancer biology, the genetic basis for hereditary ovarian cancer, staging and the role of cytoreductive surgery, and more effective chemotherapy, resulting in ...
openaire +2 more sources
Obstetrics & Gynecology, 2001
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
S H, Olson +5 more
openaire +2 more sources
To examine the symptoms of ovarian cancer in patients compared with symptoms experienced by healthy women using a case-control design.Cases (n = 168) were women with ovarian cancer diagnosed at two hospitals in New York between 1994 and 1997 who were interviewed shortly after diagnosis.
S H, Olson +5 more
openaire +2 more sources
Cancer, 1993
AbstractTaxol is a structurally complex natural plant product with a novel mechanism of action. The supply of this drug is limited by its low abundance in the bark of the slow‐growing yew tree from which it is extracted. The chemical complexity of taxol has hampered the development of a feasible process to synthesize large quantities.
C D, Runowicz +4 more
openaire +2 more sources
AbstractTaxol is a structurally complex natural plant product with a novel mechanism of action. The supply of this drug is limited by its low abundance in the bark of the slow‐growing yew tree from which it is extracted. The chemical complexity of taxol has hampered the development of a feasible process to synthesize large quantities.
C D, Runowicz +4 more
openaire +2 more sources
The Lancet, 1969
Abstract A family is described in which 5 sisters and their mother had ovarian cancer. Prophylactic oophorectomy was done in five females in the next generation. None of the ovaries showed histological evidence of ovarian carcinoma.
A C, Lewis, B C, Davison
openaire +2 more sources
Abstract A family is described in which 5 sisters and their mother had ovarian cancer. Prophylactic oophorectomy was done in five females in the next generation. None of the ovaries showed histological evidence of ovarian carcinoma.
A C, Lewis, B C, Davison
openaire +2 more sources
International Journal of Gynecological Cancer, 2008
Mucinous epithelial ovarian cancer (mEOC) accounts for approximately 10% of EOCs. Patients presenting with early-stage disease have an excellent prognosis, however, those with advanced disease have a poor outcome with relative resistance to standard ovarian cancer chemotherapy.
M L, Harrison, C, Jameson, M E, Gore
openaire +2 more sources
Mucinous epithelial ovarian cancer (mEOC) accounts for approximately 10% of EOCs. Patients presenting with early-stage disease have an excellent prognosis, however, those with advanced disease have a poor outcome with relative resistance to standard ovarian cancer chemotherapy.
M L, Harrison, C, Jameson, M E, Gore
openaire +2 more sources